AK Medical Buys JRI Orthopedics for $24M
AK Medical Holdings, a Beijing orthopedic implant maker, has paid $24 million to acquire JRI Orthopedics, UK. Upon completion, JRI Orthopaedics will become a wholly-owned subsidiary of the Hong Kong Stock Exchange-listed AK Medical.
Founded in 1970 by orthopaedic surgeon Ronald Furlong, JRI Orthopaedics was the first company to produce a hip implant with a hydroxyapatite coating enabling a biological bond with the patient’s bone. Apart from hip implants, it also develops and distributes total shoulder replacement implants and a range of orthobiologics.
Prior to the acquisition, JRI Orthopaedics had already entered into an exclusive distribution deal with AK Medical’s cemented, unscented and revision hip product portfolio in China.
According to AK Medical, the acquisition is in line with its long-term growth plan and will help expand the company’s product portfolio to create a dual-brand strategy, enhance its R&D capabilities and access to the international market.
Why the Oil Era Might Not Be over Yet
2026-08-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Maximum reduction of 81%! 22,000 down to $6,300 Large group of consumables with collective price cuts
-
Overview of China's medical device import and export trade in 2021
-
5 Billion! Strong Growth! Top 1 Sample Hospital Variety
-
Do You Know the Real Benefits of Eating Bird's Nest?
-
Polycarbonate PC turns out to have so many uses
-
Nation helping meet global demand for medical supplies
-
Yanan Petrochemical converted polypropylene medical non-woven fabric material
-
Medicare Payment: Grass-roots co-ordinated payment
-
Xinlitai heavy new product will be approved soon
-
The original research price of 3.5 billion pound varieties dropped by 74%
Recommend Reading
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Air Liquide to Acquire Korea’s DIG Airgas for €2.85 Billion
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
Australia New Zealand Approve GM Enzyme Stevia Sweetener From China for Food Use
-
Lithium Carbonate Prices Strongly Rebound Amid Dual Supply-and-Demand Boost
-
Fundamental Dual Support, Lithium Carbonate Price Increase Exceeds Expectations
-
Ammonium Sulfate Market Trend in October Shows a Strong Increase in China
-
Bearish Factors Exhausted, Hydrogen Peroxide Prices Still Have Room to Rise in Late May
-
Supply and Demand Game: Flexible Trends in the Chinese Melamine Market